Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

AIMS: Most trials showing benefit of beta-blocker treatment after myocardial infarction (MI) included patients with large MIs and are from an era before modern biomarker-based MI diagnosis and reperfusion treatment. The aim of the randomized evaluation of decreased usage of beta-blockers after acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Yndigegn, Troels, Lindahl, Bertil, Alfredsson, Joakim, Benatar, Jocelyne, Brandin, Lisa, Erlinge, David, Haaga, Urban, Held, Claes, Johansson, Pelle, Karlström, Patric, Kellerth, Thomas, Marandi, Toomas, Mars, Katarina, Ravn-Fischer, Annica, Sundström, Johan, Östlund, Ollie, Hofmann, Robin, Jernberg, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892870/
https://www.ncbi.nlm.nih.gov/pubmed/36513329
http://dx.doi.org/10.1093/ehjcvp/pvac070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892870/
https://www.ncbi.nlm.nih.gov/pubmed/36513329
http://dx.doi.org/10.1093/ehjcvp/pvac070

Ejemplares similares